How does dapoxetine 60mg extend ejaculatory latency time?

Dapoxetine inhibits the serotonin transporter (SERT), raising synaptic serotonin levels in spinal and supraspinal pathways that control ejaculation. This serotonergic enhancement slows ejaculatory reflex triggering, extending intravaginal ejaculatory latency time (IELT). EMA-reviewed Phase III data showed approximately a 3-fold improvement in mean IELT at the 60 mg dose compared to placebo, alongside significant gains in patient-rated ejaculatory control.

Can dapoxetine be safely taken together with sildenafil or tadalafil?

Yes — dapoxetine and PDE5 inhibitors such as sildenafil target entirely separate mechanisms: serotonergic modulation versus phosphodiesterase-5 blockade. Published combination studies confirm no significant pharmacokinetic interaction between the two drug classes. However, the combination may modestly lower blood pressure, so the first co-administration should be taken seated or supine, and rapid postural changes avoided for at least two hours.

When should I take Dapoxy-DX 60mg before sexual activity?

Take one Dapoxy-DX 60mg tablet 1 to 3 hours before anticipated intercourse. The drug reaches peak plasma concentration (Tmax) within 1–2 hours, aligning the window of maximum serotonergic activity with the period of sexual engagement. Because its parent compound half-life is approximately 1.3 hours, it clears quickly afterward, avoiding next-day systemic accumulation — a major advantage over daily SSRI therapy.

Are Dapoxy-DX tablets suitable for splitting or can they be swallowed whole only?

Dapoxy-DX tablets are formulated as standard solid oral units intended to be swallowed whole with a full glass of water. Splitting is generally not recommended because it may disrupt the homogeneous distribution of the API within the tablet matrix and alter the dissolution profile. For dose titration needs (e.g., starting at 30 mg), a separate lower-strength product is the appropriate approach rather than manually dividing a 60 mg tablet.

How are the 100 tablets packaged, and does the packaging protect potency during storage?

Each Dapoxy-DX unit is packed in PVC/aluminium blister strips, providing a moisture- and light-resistant primary barrier that preserves tablet integrity throughout its shelf life. The blister format also supports discreet, individual-dose dispensing. Secondary packaging carries batch number and expiry data; a full certificate of analysis is available per batch, confirming HPLC-verified potency at release. (2) angle_used

Lab Tested

Shree Venkatesh

Dapoxy-DX 60mg/tab 100 Tabletten by Shree Venkatesh

Name: Dapoxy-DX 60mg/tab 100 Tablets by Shree Venkatesh
Brand: Shree Venkatesh
SKU: POT-DAPO-SHR-001
Price: 80.00 EUR
Availability: InStock
Rating: 4.5 (2 reviews)

4.5 (2 reviews)

Dapoxy-DX 60mg contains dapoxetine hydrochloride, a short-acting SSRI formulated for on-demand management of premature ejaculation in adult men, with a pharmacokinetic profile that supports concurrent use alongside PDE5 inhibitors including sildenafil and tadalafil. The pack format — 100 tablets per unit — meets the volume requirements of men running extended on-demand protocols or combination regimens addressing both ejaculatory control and erectile function. Every batch is released against HPLC-confirmed API purity, LAL endotoxin screening, and USP Apparatus II dissolution data produced within a WHO-GMP-certified manufacturing facility operated by Shree Venkatesh.

€80.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

On-demand dosing eliminates the need for daily SSRI regimens and chronic systemic exposure.
60 mg strength corresponds to the highest clinically studied dose for maximum ejaculatory control improvement.
Short parent-compound half-life (~1.3 h) ensures rapid clearance and no residual sedation the following day.
Mechanistically compatible with sildenafil, tadalafil, and vardenafil — addresses both PE and ED in one protocol.
100-tablet pack supports extended-use regimens or shared protocols without frequent reordering.
HPLC-confirmed API purity at batch release underpins consistent in-use performance.
WHO-GMP-certified production provides regulatory-grade traceability from raw API through finished tablet.

Phase	Dosage	Note
Initiation (Weeks 1–2)	30 mg (half-strength equivalent) or 60 mg	Begin at the lower end if combining with a PDE5 inhibitor for the first time; assess cardiovascular tolerance (blood pressure response) before committing to full 60 mg dose.
Maintenance (Weeks 3+)	60 mg on-demand	Standard clinical dose; take 1–3 hours pre-intercourse. Do not exceed one dose per 24-hour period.
Combination Protocol (with PDE5 Inhibitor)	Dapoxetine 60 mg + sildenafil/tadalafil per respective standard dose	Administer both agents simultaneously 1–2 hours before activity; ensure adequate hydration and avoid alcohol to minimise orthostatic hypotension risk.
Cycle Duration	As-needed (no fixed cycle length)	Dapoxetine is not a hormone; no post-cycle therapy (PCT) is required. Discontinuation carries no withdrawal risk at on-demand use frequency.

Key takeaways

Take Dapoxy-DX 60mg on-demand, 1–3 hours before intercourse.
Combine safely with PDE5 inhibitors to target both ejaculatory and erectile concerns.
Expect approximately 3-fold IELT extension versus placebo at the 60 mg dose.
Choose a short-acting SSRI to avoid daily dosing and receptor desensitisation.
Verify potency batch-by-batch via the included HPLC-confirmed certificate of analysis.

What Dapoxy-DX Is and How It Addresses Premature Ejaculation

Dapoxy-DX is a solid oral dosage form containing 60 mg of dapoxetine hydrochloride per tablet, formulated specifically for on-demand pharmacological management of premature ejaculation in adult men. Dapoxetine inhibits the serotonin transporter (SERT), thereby increasing synaptic serotonin concentrations in neural pathways that regulate the ejaculatory reflex — an effect that translates clinically into measurable extension of intravaginal ejaculatory latency time (IELT). In pivotal Phase III trials reviewed by the EMA, dapoxetine 60 mg extended mean IELT approximately 3-fold compared to placebo, with patient-reported control scores improving across all validated scales. Unlike conventional daily SSRIs, dapoxetine reaches peak plasma concentration (Tmax) within 1–2 hours and clears rapidly, making it practical for single-dose, pre-intercourse use rather than chronic therapy.

Combining Dapoxetine with PDE5 Inhibitors

Dapoxetine pairs clinically with PDE5 inhibitors — including sildenafil, tadalafil, and vardenafil — to address both core dimensions of male sexual dysfunction concurrently. Sildenafil enhances penile blood flow by blocking phosphodiesterase type 5, while dapoxetine simultaneously delays ejaculation through central serotonergic modulation; together they target distinct physiological pathways without pharmacokinetic antagonism. Clinical data from combination-use studies show that co-administration does not produce clinically significant pharmacokinetic interactions, although orthostatic hypotension risk requires monitoring, particularly during the first dose. Men using a PDE5 inhibitor alongside Dapoxy-DX should remain adequately hydrated and avoid rapid postural changes within the first two hours after ingestion.

Dosing Window and Practical Timing

The standard protocol places dapoxetine 60 mg intake 1–3 hours before anticipated sexual activity, aligning the active window with peak plasma exposure. Dapoxetine's short half-life of approximately 1.3 hours for the parent compound — and an active metabolite, desmethyldapoxetine, with a longer terminal half-life — means effective serotonergic enhancement spans the critical pre-ejaculatory period without overnight systemic accumulation. This pharmacokinetic profile sets Dapoxy-DX apart from daily SSRI regimens where persistent receptor desensitisation can blunt desired effects over time.

Manufacturing and Quality Assurance

Every batch of Dapoxy-DX undergoes API identity and purity confirmation by HPLC, endotoxin screening via the Limulus Amebocyte Lysate (LAL) method, and in-process dissolution testing aligned to USP Apparatus II standards — all executed within Shree Venkatesh's WHO-GMP-certified production environment.

Usage

Confirm timing: plan to take Dapoxy-DX 60mg exactly 1–3 hours before anticipated sexual activity to align peak plasma exposure (Tmax 1–2 h) with the critical pre-ejaculatory window.
Hydrate fully: swallow the tablet whole with at least 240 ml (8 oz) of water — adequate hydration reduces nausea, the most common transient side effect.
Avoid alcohol: do not consume alcohol within 4 hours before or after dosing; ethanol potentiates dapoxetine-related dizziness and orthostatic hypotension.
If co-administering a PDE5 inhibitor: take both agents at the same time; remain seated or supine for 20–30 minutes after ingestion and rise slowly to minimise blood pressure dip.
Observe the 24-hour limit: take no more than one 60 mg tablet within any 24-hour period regardless of sexual activity frequency.
Store correctly: keep blister strips in a cool, dry location below 25 °C, away from direct sunlight; do not remove tablets from the blister until immediately before use to preserve foil-seal integrity.

Warnings

Contraindications: Dapoxetine is contraindicated in men with significant cardiac conditions including heart failure, conduction abnormalities, and ischaemic heart disease. Concurrent use of monoamine oxidase inhibitors (MAOIs) — including reversible agents such as linezolid — is absolutely prohibited due to risk of serotonin syndrome. Lithium, thioridazine, and serotonin-norepinephrine reuptake inhibitors (SNRIs) are likewise incompatible. Severe hepatic impairment (Child-Pugh Class C) precludes use due to substantially elevated dapoxetine exposure.

Side Effects: The most frequently reported adverse events in clinical trials are nausea (approx. 12–22% at 60 mg), headache, dizziness, and diarrhoea. Syncope or pre-syncope (transient loss of consciousness) has been documented in a small percentage of users, typically within the first hour after ingestion — adopt a seated position when dapoxetine first takes effect. Sexual dysfunction beyond the intended delay (e.g., delayed orgasm or anorgasmia) occurs in a minority.

Monitoring: Blood pressure should be assessed before initiating a dapoxetine–PDE5 inhibitor combination protocol, particularly in men with borderline-low baseline values. First-dose monitoring in a controlled setting is advisable when combining with sildenafil or tadalafil. Report any mood changes — including low mood or suicidal ideation — immediately, as these are class-effect risks associated with serotonergic agents.

PCT: Dapoxetine does not suppress the hypothalamic-pituitary-gonadal (HPG) axis, does not alter endogenous testosterone production, and carries no androgenic or anabolic activity. No post-cycle therapy protocol is required at any point following on-demand use. Discontinuation of dapoxetine at as-needed frequency does not produce withdrawal symptoms or rebound premature ejaculation beyond baseline.

Frequently asked questions

How does dapoxetine 60mg extend ejaculatory latency time?: Dapoxetine inhibits the serotonin transporter (SERT), raising synaptic serotonin levels in spinal and supraspinal pathways that control ejaculation. This serotonergic enhancement slows ejaculatory reflex triggering, extending intravaginal ejaculatory latency time (IELT). EMA-reviewed Phase III data showed approximately a 3-fold improvement in mean IELT at the 60 mg dose compared to placebo, alongside significant gains in patient-rated ejaculatory control.
Can dapoxetine be safely taken together with sildenafil or tadalafil?: Yes — dapoxetine and PDE5 inhibitors such as sildenafil target entirely separate mechanisms: serotonergic modulation versus phosphodiesterase-5 blockade. Published combination studies confirm no significant pharmacokinetic interaction between the two drug classes. However, the combination may modestly lower blood pressure, so the first co-administration should be taken seated or supine, and rapid postural changes avoided for at least two hours.
When should I take Dapoxy-DX 60mg before sexual activity?: Take one Dapoxy-DX 60mg tablet 1 to 3 hours before anticipated intercourse. The drug reaches peak plasma concentration (Tmax) within 1–2 hours, aligning the window of maximum serotonergic activity with the period of sexual engagement. Because its parent compound half-life is approximately 1.3 hours, it clears quickly afterward, avoiding next-day systemic accumulation — a major advantage over daily SSRI therapy.
Are Dapoxy-DX tablets suitable for splitting or can they be swallowed whole only?: Dapoxy-DX tablets are formulated as standard solid oral units intended to be swallowed whole with a full glass of water. Splitting is generally not recommended because it may disrupt the homogeneous distribution of the API within the tablet matrix and alter the dissolution profile. For dose titration needs (e.g., starting at 30 mg), a separate lower-strength product is the appropriate approach rather than manually dividing a 60 mg tablet.
How are the 100 tablets packaged, and does the packaging protect potency during storage?: Each Dapoxy-DX unit is packed in PVC/aluminium blister strips, providing a moisture- and light-resistant primary barrier that preserves tablet integrity throughout its shelf life. The blister format also supports discreet, individual-dose dispensing. Secondary packaging carries batch number and expiry data; a full certificate of analysis is available per batch, confirming HPLC-verified potency at release. (2) angle_used

Manufacturer

Shree Venkatesh was established in India with a founding mission centred on accessible, export-quality pharmaceutical manufacturing — a heritage that continues to define its operational identity across more than two decades of production. The company holds WHO-GMP certification for its solid oral dosage facilities, a credential that governs every stage of the Dapoxy-DX manufacturing chain: from incoming raw API qualification through finished-product release testing. Analytical controls applied to each Dapoxy-DX batch include HPLC-based quantification of dapoxetine hydrochloride for identity and purity, dissolution profiling conducted under USP Apparatus II parameters, and LAL (Limulus Amebocyte Lysate) endotoxin screening on aqueous process intermediates. Shree Venkatesh's export track record spans multiple regulated markets, with documentation standards — including full batch certificates of analysis — structured to meet the expectations of EU and UK import frameworks.

Product details

Brand	Shree Venkatesh
Active ingredient	dapoxetine
Also known as	Dapoxetin, Priligy, Dapoxy-DX, Shree Venkatesh Dapoxetin
Strength	60 mg
Form	Tabletten
Pack size	100 pieces
Item number	POT-DAPO-SHR-001

Reviews

4.5/5

2 reviews

Rating: 5 out of 5 starsbenchpress_5Verified purchaseJul 28, 2026
Exactly what I needed
60mg tabs, well dosed, effect is noticeable within about an hour. Shipping was discreet, bubble wrapped properly, arrived to the UK in eight days. Will be a regular purchase for me.
Rating: 4 out of 5 starsthor_81Verified purchaseJun 22, 2026
Good stuff, price stings a bit
Product works well, can't fault the quality at 60mg. Only gripe is it's a touch pricey per tab compared to some other suppliers I've used. That said the quality is consistent and it does what it says on the tin so four stars feels fair.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00

Stack it with

Pairs well with these products.

High Concentration